Huadong Medicine Co., Ltd
000963
Xếp hạng trong cổ phiếu
#2704
Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in... Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in China, primarily focused on the creation, production, and distribution of a wide variety of medicinal products. Its extensive product catalog encompasses traditional Chinese patent medicines, immunosuppressive agents, endocrine treatments, digestive system remedies, cancer therapeutics, cardiovascular medications, and antibiotics. The company also supplies medical devices and offers solutions in the field of aesthetic medicine. Noteworthy product lines include gastrointestinal agents and Active Pharmaceutical Ingredients (APIs). Beyond its core pharmaceutical activities, Huadong Medicine is involved in the manufacturing and management of both traditional Chinese and Western raw medicines, prepared formulations, and health supplements. Its operations extend to the wholesale trade of Traditional Chinese Medicine (TCM) ingredients, prepared TCM decoction pieces, and various chemical preparations, complemented by warehousing and logistical services. A significant area of focus for the company is the research, development, manufacturing, and commercialization of aesthetic medicine products. Established in 1993, Huadong Medicine Co., Ltd maintains its corporate headquarters in Hangzhou, China.
Giá cổ phiếu
$3.89
Vốn hóa thị trường
$6.83B
Thay đổi (1 ngày)
-2.22%
Thay đổi (1 năm)
-30.58%
Quốc gia
CN
Giao dịch Huadong Medicine Co., Ltd (000963)
Danh mục
Healthcare
EPS của Huadong Medicine Co., Ltd (000963)
EPS tính đến June 2026 TTM: $0.30
Theo các báo cáo tài chính mới nhất và giá cổ phiếu của Huadong Medicine Co., Ltd, EPS hiện tại của công ty (TTM) là $0.30. Vào cuối năm 2024, công ty có EPS là $0.28, tăng so với EPS năm 2023 là $0.23.
Lịch sử EPS của Huadong Medicine Co., Ltd từ 2001 đến 2026
EPS vào cuối mỗi năm
| Năm | EPS | Thay đổi |
|---|---|---|
| 2026 (TTM) | $0.30 | 5.36% |
| 2025 | $0.28 | 1.20% |
| 2024 | $0.28 | 20.31% |
| 2023 | $0.23 | 10.42% |
| 2022 | $0.21 | -0.19% |
| 2021 | $0.21 | -15.74% |
| 2020 | $0.25 | 6.62% |
| 2019 | $0.23 | 23.31% |
| 2018 | $0.19 | 19.58% |
| 2017 | $0.16 | 31.21% |
| 2016 | $0.12 | 10.85% |
| 2015 | $0.11 | 39.10% |
| 2014 | $0.08 | 27.05% |
| 2013 | $0.06 | 26.82% |
| 2012 | $0.05 | 26.25% |
| 2011 | $0.04 | 25.74% |
| 2010 | $0.03 | -13.92% |
| 2009 | $0.04 | 118.63% |
| 2008 | $0.02 | 6.62% |
| 2007 | $0.02 | 69.66% |
| 2006 | $0.01 | 45.90% |
| 2005 | $0.01 | 221.05% |
| 2004 | 0.00 | 0.00% |
| 2003 | 0.00 | -34.48% |
| 2002 | 0.00 | -12.12% |
| 2001 | 0.00 | 0.00% |
EPS cho các công ty hoặc đối thủ cạnh tranh tương tự
| Công ty | EPS | Chênh lệch EPS | Quốc gia |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 88.58% |
IN
|
